1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
01/29/2024 | LRN | Buy Now | Stride | $61.53 | 21.89% | Citigroup | Thomas Singlehurst | $70 → $75 | Maintains | Buy | Get Alert |
01/25/2024 | LRN | Buy Now | Stride | $61.53 | 17.02% | BMO Capital | Jeffrey Silber | $71 → $72 | Maintains | Outperform | Get Alert |
01/24/2024 | LRN | Buy Now | Stride | $61.53 | 5.64% | Morgan Stanley | Greg Parrish | $60 → $65 | Maintains | Equal-Weight | Get Alert |
01/24/2024 | LRN | Buy Now | Stride | $61.53 | 21.89% | Barrington Research | Alexander Paris | $70 → $75 | Maintains | Outperform | Get Alert |
12/04/2023 | LRN | Buy Now | Stride | $61.53 | 13.77% | Barrington Research | Alexander Paris | → $70 | Reiterates | Outperform → Outperform | Get Alert |
11/16/2023 | LRN | Buy Now | Stride | $61.53 | 8.89% | BMO Capital | Jeffrey Silber | $57 → $67 | Maintains | Outperform | Get Alert |
11/16/2023 | LRN | Buy Now | Stride | $61.53 | -2.49% | Morgan Stanley | Greg Parrish | $57 → $60 | Maintains | Equal-Weight | Get Alert |
10/26/2023 | LRN | Buy Now | Stride | $61.53 | -7.36% | BMO Capital | Jeffrey Silber | $50 → $57 | Maintains | Outperform | Get Alert |
10/25/2023 | LRN | Buy Now | Stride | $61.53 | -2.49% | Barrington Research | Alexander Paris | $50 → $60 | Maintains | Outperform | Get Alert |
10/25/2023 | LRN | Buy Now | Stride | $61.53 | -7.36% | Morgan Stanley | Greg Parrish | $52 → $57 | Maintains | Equal-Weight | Get Alert |
08/16/2023 | LRN | Buy Now | Stride | $61.53 | -18.74% | Barrington Research | Alexander Paris | → $50 | Reiterates | Outperform → Outperform | Get Alert |
08/16/2023 | LRN | Buy Now | Stride | $61.53 | -15.49% | Morgan Stanley | Greg Parrish | $50 → $52 | Maintains | Equal-Weight | Get Alert |
08/16/2023 | LRN | Buy Now | Stride | $61.53 | -18.74% | BMO Capital | Jeffrey Silber | $49 → $50 | Maintains | Outperform | Get Alert |
04/26/2023 | LRN | Buy Now | Stride | $61.53 | -18.74% | Morgan Stanley | Greg Parrish | $46 → $50 | Maintains | Equal-Weight | Get Alert |
04/14/2023 | LRN | Buy Now | Stride | $61.53 | -18.74% | Barrington Research | Alexander Paris | → $50 | Reiterates | → Outperform | Get Alert |
03/10/2023 | LRN | Buy Now | Stride | $61.53 | -25.24% | Morgan Stanley | Greg Parrish | → $46 | Downgrade | Overweight → Equal-Weight | Get Alert |
01/26/2023 | LRN | Buy Now | Stride | $61.53 | -21.99% | BMO Capital | Jeffrey Silber | $47 → $48 | Maintains | Outperform | Get Alert |
01/25/2023 | LRN | Buy Now | Stride | $61.53 | -18.74% | Barrington Research | Alexander Paris | → $50 | Reiterates | → Outperform | Get Alert |
01/25/2023 | LRN | Buy Now | Stride | $61.53 | -25.24% | Morgan Stanley | Greg Parrish | $41 → $46 | Maintains | Overweight | Get Alert |
The latest price target for Stride (NYSE: LRN) was reported by Citigroup on January 29, 2024. The analyst firm set a price target for $75.00 expecting LRN to rise to within 12 months (a possible 21.89% upside). 15 analyst firms have reported ratings in the last year.
The latest analyst rating for Stride (NYSE: LRN) was provided by Citigroup, and Stride maintained their buy rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Stride, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Stride was filed on January 29, 2024 so you should expect the next rating to be made available sometime around January 29, 2025.
While ratings are subjective and will change, the latest Stride (LRN) rating was a maintained with a price target of $70.00 to $75.00. The current price Stride (LRN) is trading at is $61.53, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.